Published in Virology on November 28, 2006
Viral quasispecies evolution. Microbiol Mol Biol Rev (2012) 2.69
"Bird biting" mosquitoes and human disease: a review of the role of Culex pipiens complex mosquitoes in epidemiology. Infect Genet Evol (2011) 2.19
RNAi targeting of West Nile virus in mosquito midguts promotes virus diversification. PLoS Pathog (2009) 2.13
Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog (2010) 1.67
Mosquitoes put the brake on arbovirus evolution: experimental evolution reveals slower mutation accumulation in mosquito than vertebrate cells. PLoS Pathog (2009) 1.56
Host alternation of chikungunya virus increases fitness while restricting population diversity and adaptability to novel selective pressures. J Virol (2010) 1.51
Dengue--quo tu et quo vadis? Viruses (2011) 1.50
Genetic diversity and purifying selection in West Nile virus populations are maintained during host switching. Virology (2008) 1.29
Characterization of mosquito-adapted West Nile virus. J Gen Virol (2008) 1.21
Population variation of West Nile virus confers a host-specific fitness benefit in mosquitoes. Virology (2010) 1.20
Vector-borne transmission imposes a severe bottleneck on an RNA virus population. PLoS Pathog (2012) 1.16
Evolution in health and medicine Sackler colloquium: The comparative genomics of viral emergence. Proc Natl Acad Sci U S A (2009) 1.16
Insights into arbovirus evolution and adaptation from experimental studies. Viruses (2010) 1.15
West Nile virus experimental evolution in vivo and the trade-off hypothesis. PLoS Pathog (2011) 1.15
Factors shaping the adaptive landscape for arboviruses: implications for the emergence of disease. Future Microbiol (2013) 1.11
Tracking Dengue Virus Intra-host Genetic Diversity during Human-to-Mosquito Transmission. PLoS Negl Trop Dis (2015) 1.10
Vector-virus interactions and transmission dynamics of West Nile virus. Viruses (2013) 1.09
West Nile virus genetic diversity is maintained during transmission by Culex pipiens quinquefasciatus mosquitoes. PLoS One (2011) 1.08
Experimental passage of St. Louis encephalitis virus in vivo in mosquitoes and chickens reveals evolutionarily significant virus characteristics. PLoS One (2009) 1.06
Hidden virulence determinants in a viral quasispecies in vivo. J Virol (2008) 1.06
Adaptation of two flaviviruses results in differences in genetic heterogeneity and virus adaptability. J Gen Virol (2007) 1.05
West Nile virus population genetics and evolution. Infect Genet Evol (2011) 1.02
Initial fitness recovery of HIV-1 is associated with quasispecies heterogeneity and can occur without modifications in the consensus sequence. PLoS One (2010) 1.02
Alphavirus mutator variants present host-specific defects and attenuation in mammalian and insect models. PLoS Pathog (2014) 1.00
Cooperative interactions in the West Nile virus mutant swarm. BMC Evol Biol (2012) 0.95
The role of RNA interference (RNAi) in arbovirus-vector interactions. Viruses (2015) 0.93
Identification of genetic determinants of a tick-borne flavivirus associated with host-specific adaptation and pathogenicity. Virology (2008) 0.92
Characterization of Rabensburg virus, a flavivirus closely related to West Nile virus of the Japanese encephalitis antigenic group. PLoS One (2012) 0.90
Nonconsensus West Nile virus genomes arising during mosquito infection suppress pathogenesis and modulate virus fitness in vivo. J Virol (2011) 0.88
Topology of evolving, mutagenized viral populations: quasispecies expansion, compression, and operation of negative selection. BMC Evol Biol (2008) 0.88
Arboviral bottlenecks and challenges to maintaining diversity and fitness during mosquito transmission. Viruses (2014) 0.87
Genetic analysis of West Nile virus isolates from an outbreak in Idaho, United States, 2006-2007. Int J Environ Res Public Health (2013) 0.87
Experimental evolution of an RNA virus in wild birds: evidence for host-dependent impacts on population structure and competitive fitness. PLoS Pathog (2015) 0.86
Changes in population dynamics in mutualistic versus pathogenic viruses. Viruses (2011) 0.84
Point mutations in the West Nile virus (Flaviviridae; Flavivirus) RNA-dependent RNA polymerase alter viral fitness in a host-dependent manner in vitro and in vivo. Virology (2012) 0.84
Genetic Drift during Systemic Arbovirus Infection of Mosquito Vectors Leads to Decreased Relative Fitness during Host Switching. Cell Host Microbe (2016) 0.83
Sequence-Specific Fidelity Alterations Associated with West Nile Virus Attenuation in Mosquitoes. PLoS Pathog (2015) 0.83
In-depth characterization of viral isolates from plasma and cells compared with plasma circulating quasispecies in early HIV-1 infection. PLoS One (2012) 0.80
Modulation of flavivirus population diversity by RNA interference. J Virol (2015) 0.80
Dynamics of in vitro fitness recovery of HIV-1. J Virol (2010) 0.79
Temporal and spatial alterations in mutant swarm size of St. Louis encephalitis virus in mosquito hosts. Infect Genet Evol (2011) 0.78
The number and genetic relatedness of transmitted/founder virus impact clinical outcome in vaginal R5 SHIVSF162P3N infection. Retrovirology (2014) 0.78
Ultra-deep pyrosequencing of partial surface protein genes from infectious Salmon Anaemia virus (ISAV) suggest novel mechanisms involved in transition to virulence. PLoS One (2013) 0.77
Persistence of multiple genetic lineages within intrahost populations of Ross River virus. J Virol (2011) 0.77
Arbovirus-mosquito interactions: RNAi pathway. Curr Opin Virol (2015) 0.76
West Nile virus adaptation to ixodid tick cells is associated with phenotypic trade-offs in primary hosts. Virology (2015) 0.76
West Nile Virus Population Structure, Injury, and Interferon-Stimulated Gene Expression in the Brain From a Fatal Case of Encephalitis. Open Forum Infect Dis (2015) 0.76
Genetic Drift, Purifying Selection and Vector Genotype Shape Dengue Virus Intra-host Genetic Diversity in Mosquitoes. PLoS Genet (2016) 0.76
Complexity of virus-vector interactions. Curr Opin Virol (2016) 0.75
Dynamics of West Nile virus evolution in mosquito vectors. Curr Opin Virol (2016) 0.75
Analysis of coevolution in nonstructural proteins of chikungunya virus. Virol J (2016) 0.75
Genomic approaches for understanding dengue: insights from the virus, vector, and host. Genome Biol (2016) 0.75
Sendai virus intra-host population dynamics and host immunocompetence influence viral virulence during in vivo passage. Virus Evol (2016) 0.75
The role of environmental factors on the evolution of phenotypic diversity in vesicular stomatitis virus populations. J Gen Virol (2012) 0.75
Transmission bottlenecks and RNAi collectively influence tick-borne flavivirus evolution. Virus Evol (2016) 0.75
Rapid evolution of RNA genomes. Science (1982) 14.76
The hypercycle. A principle of natural self-organization. Part A: Emergence of the hypercycle. Naturwissenschaften (1977) 7.19
Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature (2005) 6.78
HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J Acquir Immune Defic Syndr (1989) 6.16
Nucleotide sequence heterogeneity of an RNA phage population. Cell (1978) 5.55
The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science (2000) 5.49
Genetic and phenotypic variation of West Nile virus in New York, 2000-2003. Am J Trop Med Hyg (2004) 3.34
Infectious cDNA clone of the epidemic west nile virus from New York City. J Virol (2002) 3.21
Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype. Virology (2005) 3.14
Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology (2002) 2.96
Genetic and fitness changes accompanying adaptation of an arbovirus to vertebrate and invertebrate cells. J Virol (1999) 2.78
Genetic variation in West Nile virus from naturally infected mosquitoes and birds suggests quasispecies structure and strong purifying selection. J Gen Virol (2005) 2.58
Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes. Science (2006) 2.43
Lack of evolutionary stasis during alternating replication of an arbovirus in insect and mammalian cells. J Mol Biol (1999) 2.28
Detection by enzyme-linked immunosorbent assay of antibodies to West Nile virus in birds. Emerg Infect Dis (2002) 2.22
Genetic diversity and slow rates of evolution in New World alphaviruses. Curr Top Microbiol Immunol (1992) 2.12
Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome. Proc Natl Acad Sci U S A (2002) 2.04
Fitness alteration of foot-and-mouth disease virus mutants: measurement of adaptability of viral quasispecies. J Virol (1991) 1.89
Evolution of alphaviruses in the eastern equine encephalomyelitis complex. J Virol (1994) 1.86
Clinical significance of hepatitis C virus genotypes and quasispecies. Semin Liver Dis (2000) 1.75
Evolutionary influences in arboviral disease. Curr Top Microbiol Immunol (2006) 1.64
Genetic diversity in RNA virus quasispecies is controlled by host-virus interactions. J Virol (2001) 1.62
Effect of alternating passage on adaptation of sindbis virus to vertebrate and invertebrate cells. J Virol (2005) 1.57
A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice. Virology (2006) 1.54
Foot-and-mouth disease virus populations are quasispecies. Curr Top Microbiol Immunol (1992) 1.53
Phylogeny of North American Powassan virus. J Gen Virol (2001) 1.29
Duration and fitness dependence of quasispecies memory. J Mol Biol (2002) 1.18
Replication of phage RNA. Prog Nucleic Acid Res Mol Biol (1967) 1.15
A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus. Virology (2006) 1.08
Quasispecies in wild-type tula hantavirus populations. J Virol (1996) 1.06
Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity. Virology (2006) 1.05
Early changes in quasispecies repertoire in HIV-infected infants: correlation with disease progression. AIDS Res Hum Retroviruses (2000) 0.96
Molecular self-organization and the early stages of evolution. Q Rev Biophys (1971) 0.95
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med (2005) 5.09
West Nile virus epidemics in North America are driven by shifts in mosquito feeding behavior. PLoS Biol (2006) 4.46
Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology (2002) 3.79
Impact of daily temperature fluctuations on dengue virus transmission by Aedes aegypti. Proc Natl Acad Sci U S A (2011) 3.57
Host heterogeneity dominates West Nile virus transmission. Proc Biol Sci (2006) 3.54
2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature (2010) 3.49
A global perspective on the epidemiology of West Nile virus. Annu Rev Entomol (2008) 3.42
Genetic and phenotypic variation of West Nile virus in New York, 2000-2003. Am J Trop Med Hyg (2004) 3.34
Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype. Virology (2005) 3.14
Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J Virol (2010) 3.10
Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. J Virol (2005) 3.08
West Nile virus 5'-cap structure is formed by sequential guanine N-7 and ribose 2'-O methylations by nonstructural protein 5. J Virol (2006) 3.07
Structure and function of flavivirus NS5 methyltransferase. J Virol (2007) 2.93
A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity. Cell Host Microbe (2008) 2.93
Temperature, viral genetics, and the transmission of West Nile virus by Culex pipiens mosquitoes. PLoS Pathog (2008) 2.88
West Nile virus risk assessment and the bridge vector paradigm. Emerg Infect Dis (2005) 2.88
A newly emergent genotype of West Nile virus is transmitted earlier and more efficiently by Culex mosquitoes. Am J Trop Med Hyg (2007) 2.84
Genetic variation in West Nile virus from naturally infected mosquitoes and birds suggests quasispecies structure and strong purifying selection. J Gen Virol (2005) 2.58
NS5 of dengue virus mediates STAT2 binding and degradation. J Virol (2009) 2.42
The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway. J Virol (2004) 2.37
C6/36 Aedes albopictus cells have a dysfunctional antiviral RNA interference response. PLoS Negl Trop Dis (2010) 2.29
West Nile virus. Lancet Neurol (2007) 2.26
Quantitation of flaviviruses by fluorescent focus assay. J Virol Methods (2006) 2.25
Chikungunya fever in the United States: a fifteen year review of cases. Clin Infect Dis (2011) 2.25
Detection by enzyme-linked immunosorbent assay of antibodies to West Nile virus in birds. Emerg Infect Dis (2002) 2.22
An adenosine nucleoside inhibitor of dengue virus. Proc Natl Acad Sci U S A (2009) 2.20
"Bird biting" mosquitoes and human disease: a review of the role of Culex pipiens complex mosquitoes in epidemiology. Infect Genet Evol (2011) 2.19
Serologic evidence of West Nile virus transmission, Jamaica, West Indies. Emerg Infect Dis (2003) 2.19
Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification. Nucleic Acids Res (2012) 2.19
RNAi targeting of West Nile virus in mosquito midguts promotes virus diversification. PLoS Pathog (2009) 2.13
Mosquitoes inoculate high doses of West Nile virus as they probe and feed on live hosts. PLoS Pathog (2007) 2.13
Strategies for development of Dengue virus inhibitors. Antiviral Res (2010) 2.11
Dynamics of flavivirus infection in mosquitoes. Adv Virus Res (2003) 2.06
The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci Transl Med (2012) 1.95
Highly sensitive and specific detection of rare variants in mixed viral populations from massively parallel sequence data. PLoS Comput Biol (2012) 1.93
Identification of mosquito bloodmeals using polymerase chain reaction (PCR) with order-specific primers. J Med Entomol (2003) 1.90
Ten years of dengue drug discovery: progress and prospects. Antiviral Res (2013) 1.84
Virus detection protocols for west nile virus in vertebrate and mosquito specimens. J Clin Microbiol (2003) 1.82
Small RNA profiling of Dengue virus-mosquito interactions implicates the PIWI RNA pathway in anti-viral defense. BMC Microbiol (2011) 1.78
Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication. J Virol (2005) 1.75
High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery. Antimicrob Agents Chemother (2005) 1.73
Triaryl pyrazoline compound inhibits flavivirus RNA replication. Antimicrob Agents Chemother (2006) 1.72
Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination. J Clin Microbiol (2003) 1.65
Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay. J Clin Microbiol (2004) 1.59
Discovery of 4-benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions. J Med Chem (2003) 1.57
West Nile virus infection of Drosophila melanogaster induces a protective RNAi response. Virology (2008) 1.56
Interaction between the cellular protein eEF1A and the 3'-terminal stem-loop of West Nile virus genomic RNA facilitates viral minus-strand RNA synthesis. J Virol (2007) 1.56
RNA structures required for production of subgenomic flavivirus RNA. J Virol (2010) 1.52
Distinct RNA elements confer specificity to flavivirus RNA cap methylation events. J Virol (2007) 1.48
Role of the mutant spectrum in adaptation and replication of West Nile virus. J Gen Virol (2007) 1.46
Tetracycline-inducible packaging cell line for production of flavivirus replicon particles. J Virol (2004) 1.44
West Nile virus methyltransferase catalyzes two methylations of the viral RNA cap through a substrate-repositioning mechanism. J Virol (2008) 1.44
The flavivirus-conserved penta-nucleotide in the 3' stem-loop of the West Nile virus genome requires a specific sequence and structure for RNA synthesis, but not for viral translation. Virology (2005) 1.43
Small molecule inhibitors that selectively block dengue virus methyltransferase. J Biol Chem (2010) 1.40
Declining growth rate of West Nile virus in North America. J Virol (2006) 1.39
A mouse cell-adapted NS4B mutation attenuates West Nile virus RNA synthesis. Virology (2006) 1.38
Enhanced early West Nile virus infection in young chickens infected by mosquito bite: effect of viral dose. Am J Trop Med Hyg (2006) 1.38
Cell-specific adaptation of two flaviviruses following serial passage in mosquito cell culture. Virology (2006) 1.37
West Nile virus genome cyclization and RNA replication require two pairs of long-distance RNA interactions. Virology (2008) 1.37
Detection of West Nile virus-infected mosquitoes and seropositive juvenile birds in the vicinity of virus-positive dead birds. Am J Trop Med Hyg (2002) 1.36
Phylogenetic and evolutionary analyses of St. Louis encephalitis virus genomes. Mol Phylogenet Evol (2008) 1.35
Short report: duration of tick attachment required for transmission of powassan virus by deer ticks. Am J Trop Med Hyg (2004) 1.33
Structure and function of the 3' terminal six nucleotides of the west nile virus genome in viral replication. J Virol (2004) 1.33
2'-O methylation of internal adenosine by flavivirus NS5 methyltransferase. PLoS Pathog (2012) 1.32
Inhibition of dengue virus by targeting viral NS4B protein. J Virol (2011) 1.31
Flavivirus methyltransferase: a novel antiviral target. Antiviral Res (2008) 1.31
Genetic influences on mosquito feeding behavior and the emergence of zoonotic pathogens. Am J Trop Med Hyg (2007) 1.30
Mosquito saliva causes enhancement of West Nile virus infection in mice. J Virol (2010) 1.30
Keratinocytes are cell targets of West Nile virus in vivo. J Virol (2011) 1.29
Genetic diversity and purifying selection in West Nile virus populations are maintained during host switching. Virology (2008) 1.29
Functional analysis of two cavities in flavivirus NS5 polymerase. J Biol Chem (2011) 1.28
Inhibition of dengue virus polymerase by blocking of the RNA tunnel. J Virol (2010) 1.28
Culex restuans (Diptera: Culicidae) relative abundance and vector competence for West Nile Virus. J Med Entomol (2005) 1.27
Spatial and temporal variation in vector competence of Culex pipiens and Cx. restuans mosquitoes for West Nile virus. Am J Trop Med Hyg (2010) 1.26
Potential high-throughput assay for screening inhibitors of West Nile virus replication. J Virol (2003) 1.25
Molecular epidemiology of eastern equine encephalitis virus, New York. Emerg Infect Dis (2008) 1.22
Characterization of mosquito-adapted West Nile virus. J Gen Virol (2008) 1.21
Biochemical and genetic characterization of dengue virus methyltransferase. Virology (2010) 1.21
Terminal structures of West Nile virus genomic RNA and their interactions with viral NS5 protein. Virology (2008) 1.20
Development and characterization of a stable luciferase dengue virus for high-throughput screening. Antiviral Res (2011) 1.20
Serologic evidence for West Nile virus transmission in Puerto Rico and Cuba. Am J Trop Med Hyg (2005) 1.20
Population variation of West Nile virus confers a host-specific fitness benefit in mosquitoes. Virology (2010) 1.20
Identification of compounds with anti-West Nile Virus activity. J Med Chem (2006) 1.19
Exclusion of West Nile virus superinfection through RNA replication. J Virol (2009) 1.19